Finance

Lists
600513:SHA
Jiangsu Lianhuan Pharmaceutical Co. Ltd
CNÂ¥16.28
-1.93%
(-0.32) 1D
Oct 9, 3:00:00 PM GMT+8  ·   CNY
All symbols
SymbolPriceChange% Change
Generating top insights for 600513...
Open
CNÂ¥16.46
High
CNÂ¥16.98
Low
CNÂ¥15.92
Mkt. cap
4.65B
Avg. vol.
9.77M
Volume
38.61M
Dividend
0.43%
Quarterly dividend
CNÂ¥0.02
Ex-dividend date
Jul 8, 2026
52-wk high
CNÂ¥32.27
52-wk low
CNÂ¥13.67
EPS
-CNÂ¥0.17
Shares outstanding
285.46M
No. of employees
2K
Open
CNÂ¥16.46
High
CNÂ¥16.98
Low
CNÂ¥15.92
Mkt. cap
4.65B
Avg. vol.
9.77M
Volume
38.61M
Dividend
0.43%
Quarterly dividend
CNÂ¥0.02
Ex-dividend date
Jul 8, 2026
52-wk high
CNÂ¥32.27
52-wk low
CNÂ¥13.67
EPS
-CNÂ¥0.17
Shares outstanding
285.46M
No. of employees
2K
News stories
From web sources and news partners
About Jiangsu Lianhuan Pharmaceutical Co. Ltd
CEO-
Employees2.13K
Founded1999
Headquarters-
SectorPharmaceutical industry
Websitelhpharma.com
Previous reportsAll values in CNY
Loading Previous Earnings...
Revenue
Net income
All values in CNY
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
797.12M
629.40M
810.63M
760.19M
Cost of goods sold
576.69M
414.86M
595.63M
525.07M
Cost of revenue
576.69M
414.86M
595.63M
525.07M
Research and development expenses
39.16M
97.69M
28.66M
34.29M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
167.54M
167.70M
162.54M
173.32M
Operating expense
201.20M
283.39M
195.29M
214.47M
Total operating expenses
777.89M
698.25M
790.92M
739.54M
Operating income
19.23M
-68.85M
19.71M
20.65M
Other non operating income
-61.00M
60.41M
-742.69K
1.60M
EBT including unusual items
6.01M
-86.11M
10.60M
11.80M
EBT excluding unusual items
-50.92M
-15.95M
10.61M
11.98M
Income tax expense
1.37M
-29.68M
3.24M
4.41M
Effective tax rate
22.86%
34.47%
30.55%
37.36%
Other operating expenses
-1.58M
10.33M
2.59M
6.26M
Net income
4.97M
-63.27M
6.42M
4.10M
Net profit margin
0.62%
-10.05%
0.79%
0.54%
Earnings per share
-
-
-
-
Interest and investment income
71.92K
630.30K
17.72K
393.42K
Interest expense
-8.75M
-7.80M
-8.37M
-9.88M
Net interest expenses
-8.67M
-7.17M
-8.35M
-9.49M
Depreciation and amortization charges
-
-
-
-
EBITDA
34.12M
-44.70M
43.85M
49.42M
Gain or loss from assets sale
5.72K
77.54K
-
-15.00K
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps